We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+46.47%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$407M
AUM Growth
+$69.8M
Cap. Flow
-$22.2M
Cap. Flow %
-5.45%
Top 10 Hldgs %
24.1%
Holding
129
New
20
Increased
20
Reduced
20
Closed
27

Top Buys

Rank Stock Value
1
VCYT icon
Veracyte
VCYT
+$8.34M
2
TWST icon
Twist Bioscience
TWST
+$6.32M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$5.16M
4
PACB icon
Pacific Biosciences
PACB
+$5.1M
5
TDOC icon
Teladoc Health
TDOC
+$4.41M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$11.4M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.49M
3
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$6.86M
4
CRSP icon
CRISPR Therapeutics
CRSP
+$5.86M
5
ARWR icon
Arrowhead Research
ARWR
+$5.76M

Sector Composition

Rank Sector Weight
1 Healthcare 45.15%
2 Technology 24.29%
3 Communication Services 9.57%
4 Consumer Discretionary 5.1%
5 Financials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
META icon
51
Meta Platforms (Facebook)
META
$1.42T
$3.28M 0.8%
12,000
-19,360
-62% -$5.31M
AMZN icon
52
Amazon
AMZN
$2.92T
$3.26M 0.8%
20,000
-71,540
-78% -$11.4M
VEEV icon
53
Veeva Systems
VEEV
$33.1B
$3.21M 0.79%
11,785
+3,500
+42% +$981K
CLH icon
54
Clean Harbors
CLH
$16.5B
$3.19M 0.78%
41,966
– –
SMCI icon
55
Super Micro Computer
SMCI
$18.4B
$3.19M 0.78%
1,007,610
– –
P
56
Everpure Inc
P
$25.7B
$3.17M 0.78%
+140,000
New +$2.68M
SNPS icon
57
Synopsys
SNPS
$74.4B
$3.16M 0.78%
12,200
– –
CARG icon
58
CarGurus
CARG
$3.27B
$3.06M 0.75%
96,464
+50,000
+108% +$1.24M
FTNT icon
59
Fortinet
FTNT
$119B
$2.99M 0.74%
100,780
– –
GH icon
60
Guardant Health
GH
$21.7B
$2.96M 0.73%
22,943
– –
FATE icon
61
Fate Therapeutics
FATE
$286M
$2.91M 0.71%
+32,000
New +$1.99M
CRM icon
62
Salesforce
CRM
$151B
$2.89M 0.71%
13,000
-1,000
-7% -$243K
UTHR icon
63
United Therapeutics
UTHR
$25.8B
$2.89M 0.71%
19,032
-3,026
-14% -$397K
AVLR
64
DELISTED
Avalara, Inc.
AVLR
$2.81M 0.69%
17,026
– –
MDGL icon
65
Madrigal Pharmaceuticals
MDGL
$10.8B
$2.71M 0.66%
+24,351
New +$2.98M
LMAT icon
66
LeMaitre Vascular
LMAT
$2.32B
$2.64M 0.65%
65,173
– –
MEDP icon
67
Medpace
MEDP
$16.1B
$2.46M 0.61%
17,698
– –
GOOGL icon
68
Alphabet (Google) Class A
GOOGL
$4.36T
$2.45M 0.6%
28,000
-100,880
-78% -$8.49M
PHR icon
69
Phreesia
PHR
$663M
$2.39M 0.59%
+44,000
New +$1.89M
CPRT icon
70
Copart
CPRT
$27B
$2.37M 0.58%
74,488
– –
UI icon
71
Ubiquiti
UI
$33.7B
$2.23M 0.55%
8,000
-6,516
-45% -$1.5M
DHR icon
72
Danaher
DHR
$137B
$2.22M 0.55%
11,280
– –
EPAM icon
73
EPAM Systems
EPAM
$5.51B
$2.18M 0.54%
6,090
-4,859
-44% -$1.62M
MPT
74
Medical Properties Trust
MPT
$2.77B
$2.18M 0.53%
99,957
– –
WIRE
75
DELISTED
Encore Wire Corp
WIRE
$2.16M 0.53%
35,700
-9,733
-21% -$503K
1 2
3
4 5

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Capital Impact Advisors held 129 positions worth $407M, up 21% from $337M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Capital Impact Advisors withdrew a net $22.2M in Q4 2020, closing 27 positions and reducing 20 holdings. Its most notable exit was Livongo Health, Inc. Common Stock, an estimated $6.86M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 31% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Capital Impact Advisors opened a new position in Veracyte worth $8.81M.

  • Capital Impact Advisors's largest Q4 2020 buy was Veracyte: 180,000 shares worth $8.81M.
  • Capital Impact Advisors added most to Twist Bioscience in Q4 2020, an estimated $6.32M increase.
  • Capital Impact Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $11.4M.
  • Capital Impact Advisors fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $6.86M.
  • Capital Impact Advisors's ten largest holdings make up 24% of its $407M portfolio in Q4 2020.
  • Capital Impact Advisors opened 20 new positions and closed 27 in Q4 2020.
  • Capital Impact Advisors's portfolio value rose 21% quarter-over-quarter to $407M.

Based on Capital Impact Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.